🇺🇸 Cyclosporine emulsion in United States
8 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 8
Most-reported reactions
- Burning Sensation — 1 report (12.5%)
- Discharge — 1 report (12.5%)
- Discomfort — 1 report (12.5%)
- Drug Ineffective — 1 report (12.5%)
- Hypersensitivity — 1 report (12.5%)
- Lacrimation Increased — 1 report (12.5%)
- Product Substitution Issue — 1 report (12.5%)
- Therapeutic Response Changed — 1 report (12.5%)
Other Immunology approved in United States
Frequently asked questions
Is Cyclosporine emulsion approved in United States?
Cyclosporine emulsion does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Cyclosporine emulsion in United States?
Baylor College of Medicine is the originator. The local marketing authorisation holder may differ — check the official source linked above.